Abbott Laboratories subsidiary Abbott India is to merge with chemical and pharmaceutical group Solvay India.

Solvay shareholders will get three shares of Abbott India for every two they hold.

Once the merger is complete, Abbott will hold about 75% in the combined entity Anui Mithani of UBS Investment Bank told the Business Line.

The news follows Abbott Laboratories’ takeover of Solvay’s Belgian pharmaceutical business in 2009 for €4.8bn ($6.4bn).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData